
Daniel T. McKillop
Partner
201-896-7115 dmckillop@sh-law.comFirm Insights
Author: Daniel T. McKillop
Date: February 2, 2018
Partner
201-896-7115 dmckillop@sh-law.comThe deadly opioid epidemic shows no signs of slowing down, despite the widespread attention it is finally receiving. At least 1,901 people died from opioid overdoses in New Jersey in 2016.
As lawmakers and public health officials grapple with how best to combat the opioid crisis, medical marijuana is emerging as a safer tool to manage pain. A new report from the National Academies of Sciences, Engineering, and Medicine, which represents one of the most comprehensive studies of recent research on the health effects of cannabis, concluded there is “strong evidence” that cannabis is effective at managing chronic pain in adults relative to a placebo.
Drug overdose deaths involving opioids have skyrocketed in recent years. Below are several startling statistics from the Centers for Disease Control and Prevention:
Several factors have contributed to the rapid increase in opioid-related overdoses, including a rise on prescriptions for the potent painkillers. Since 1999, the number of prescription opioids sold in the U.S. nearly quadrupled. However, there has not been an overall change in the amount of pain that Americans report.
The majority of opioid deaths involve individuals with no history of substance abuse. In many cases, opioid addiction starts with a valid prescription after surgery or other medical treatment. Once the opioid medication runs out or becomes too expensive, people often turn to street drugs like heroin.
In 2013, providers wrote nearly a quarter of a billion opioid prescriptions, which is enough for every American adult to have their own bottle of pills. Opioids are also increasingly prescribed for chronic pain. Although they may provide short-term relief, the medications have not proven to be an effective long-term solution.
New Jersey legalized medical marijuana in 2010 with the enactment of the New Jersey Compassionate Use Medical Marijuana Act (the “Act”). The New Jersey Department of Health implemented the Act by creating the New Jersey Medical Marijuana Program (“MMP”). The MMP authorizes approved physicians to disburse up to two ounces of medical marijuana to a registered patient during any 30-day period to treat numerous “debilitating medical conditions,” particularly where conventional treatments are ineffective or exacerbate a patient’s suffering.
The Garden State’s medical marijuana program is one of the strictest in the country.
A physician must certify that a patient has an approved debilitating medical condition to participate in the New Jersey Medicinal Marijuana Program. The current list of qualifying conditions for medical marijuana includes amyotrophic lateral sclerosis (Lou Gehrig’s disease), Multiple Sclerosis, terminal cancer, muscular dystrophy, inflammatory bowel disease, and any terminal illness. Post-traumatic stress disorder (PTSD) was added as an approved condition in 2016.
In July, the New Jersey Medicinal Marijuana Review Panel (MMRP) recommended that the Commissioner of the Department of Public Health qualify dozens of additional debilitating conditions falling within the categories of chronic pain, migraine, anxiety, and Tourette’s Syndrome for inclusion in the State’s medicinal marijuana program. However, the Department of Public Health has yet to render a final decision.
Research confirms that cannabis can be an effective pain management tool. Moreover, encouraging the prescription of medical marijuana can help curb opioid addiction. Unlike narcotic painkillers, cannabis can’t lead to a fatal overdose. The likelihood of addiction is also much lower.
A 2015 working paper by the National Bureau of Economic Research found that the existence of medical marijuana dispensaries in a state was linked to a 15 to 35 percent decrease in admissions to substance abuse treatment centers. It further found a similar decline in overdose deaths.
In Colorado, legalizing recreational cannabis resulted in a decline in opioid overdose deaths. According to a study published in the American Journal of Public Health, in the two years after Colorado implemented its recreational marijuana law, opioid deaths dropped by 6.5 percent. A 2014 study by the Johns Hopkins Bloomberg School of Public Health found similar results. The researchers estimated that prescription drug overdoses decrease 25 percent in states with medical marijuana programs that allow chronic pain patients to participate. Moreover, the effect of legalizing medical cannabis appeared to grow over time, meaning more lives were saved each additional year after the law was enacted.
While Gov. Chris Christie made the opioid crisis a top priority, he strongly opposed medical marijuana. With a change in leadership in the Garden State, it is more likely that cannabis may be considered as a viable solution to the growing health crisis of opioid overdoses.
This article is a part of a series pertaining to cannabis legalization in New Jersey and the United States at large. Prior articles in this series are below:
If you have any questions or if you would like to discuss the matter further, please contact me, Dan McKillop, at 201-806-3364.
Disclaimer: Possession, use, distribution, and/or sale of cannabis is a Federal crime and is subject to related Federal policy. Legal advice provided by Scarinci Hollenbeck, LLC is designed to counsel clients regarding the validity, scope, meaning, and application of existing and/or proposed cannabis law. Scarinci Hollenbeck, LLC will not provide assistance in circumventing Federal or state cannabis law or policy, and advice provided by our office should not be construed as such.
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Over the past year, brick-and-mortar stores have closed their doors at a record pace. Fluctuating consumer preferences, the rise of online shopping platforms, and ongoing economic uncertainty continue to put pressure on the retail industry. When a retailer seeks bankruptcy protection, a myriad of other businesses are often impacted. Whether you are a supplier, customer, […]
Author: Brian D. Spector
Since his inauguration two months ago, Donald Trump’s administration and the Congress it controls have indicated important upcoming policy changes. These changes will impact financial services policies and priorities. The changes will particularly affect cryptocurrency, as well as banking rules and regulations. Key Regulatory Changes in Cryptocurrency For example, in the burgeoning cryptocurrency business environment, […]
Author: Dan Brecher
The retail sector has experienced a wave of bankruptcy filings over the last year. Brick-and-mortar businesses in financial distress include big-name brands like Big Lots, Party City, The Container Store, and Vitamin Shoppe. When large retailers seek bankruptcy protection, they are not the only businesses impacted. Landlords can be particularly hard hit. While commercial landlords […]
Author: Brian D. Spector
The bankruptcy legal landscape presents both challenges and opportunities for businesses navigating financial distress. Understanding current bankruptcy trends can help businesses make more informed and strategic decisions. Corporate Bankruptcy Filings Trending Upwards Bankruptcy filings continued to trend upwards in 2024. According to statistics released by the Administrative Office of the U.S. Courts, personal and business […]
Author: Brian D. Spector
In December, the U.S. Securities and Exchange Commission (SEC) announced charges against two privately held companies for failing to file a Form D notice, which is generally utilized for exempt securities offerings. Here, the SEC’s enforcement sends a strong message: compliance with regulatory requirements is not optional and failure to comply can have significant consequences. […]
Author: Kenneth C. Oh
On February 14, 2025, the Office of General Counsel (OGC) of the National Labor Relations Board (NLRB) under Acting General Counsel William B. Cowen issued Memorandum 25-05, “New Process for More Efficient, Effective, Accessible and Transparent Case handling.” The Memorandum rescinds nearly all of the Memoranda issued by his direct predecessor, Jennifer Abruzzo, setting the […]
Author: Matthew F. Mimnaugh
No Aspect of the advertisement has been approved by the Supreme Court. Results may vary depending on your particular facts and legal circumstances.
Consider subscribing to our Firm Insights mailing list by clicking the button below so you can keep up to date with the firm`s latest articles covering various legal topics.
Stay informed and inspired with the latest updates, insights, and events from Scarinci Hollenbeck. Our resource library provides valuable content across a range of categories to keep you connected and ahead of the curve.
Let`s get in touch!
Sign up to get the latest from the Scarinci Hollenbeck, LLC attorneys!